Matt Roach
Director of Investor Relations
Replay available
Ironwood Pharmaceuticals, Inc. (IRWD) Q1 2024 Earnings Call
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) Q1 2024 earnings conference call, held 2024-05-09. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Tom McCourt
Chief Executive Officer
Mike Schetzlein
Chief Medical Officer
Shravan Imani
Chief Financial Officer
David Amsalem
Analyst at Piper Sandler
Chase Meeker-Bucker
Analyst at Craig Hallum
Amy Lee
Analyst at Jefferies
Jason Butler
Analyst at Citizens J&B
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Ironwood Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.523 -- 00:00:04.585 Thank you for standing by. My name is Cath and I will be your conference operator today. 00:00:04.585 -- 00:00:09.388 At this time, I would like to welcome everyone to the Ironwood Pharmaceuticals first 00:00:09.388 -- 00:00:11.550 quarter 2024 investor 00:00:11.550 -- 00:00:16.713 update call. All lines have been placed on mute to prevent any background noise. 00:00:16.713 -- 00:00:20.175 After the speaker's remarks, there will be a question and answer session. 00:00:20.175 -- 00:00:23.537 If you would like to ask a question during this time, simply press star followed by the 00:00:23.537 -- 00:00:27.900 number one on your telephone keypad. If you would like to withdraw your question, press 00:00:27.900 -- 00:00:32.943 star one again. I would now like to turn the call over to Matt Roach, Director of 00:00:32.943 -- 00:00:36.424 Industrial Relations. Please go ahead. 00:00:36.424 -- 00:00:40.927 Thank you, Cass. Good morning and thanks for joining us for our first quarter 2024 investor 00:00:40.927 -- 00:00:42.948 update. Our 00:00:42.948 -- 00:00:46.289 press release issued this morning can be found on our website. 00:00:46.289 -- 00:00:49.911 Today's call and accompanying slides include four looking statements within the meaning 00:00:49.911 -- 00:00:54.073 of the Private Securities Litigation Reform Act of 1995. 00:00:54.073 -- 00:00:58.055 Such statements involve risks and uncertainties and may cause actual results to differ 00:00:58.055 -- 00:01:03.054 materially. A discussion of these statements and risk factors is available on the current 00:01:03.054 -- 00:01:07.616 Safe Harbor Statement slide, as well as under the heading Risk Factors in our annual 00:01:07.616 -- 00:01:12.147 report on Form 10-K for the year ended Decembe...